Expert consensus on applicability assessment of real-world data of hospital-prepared traditional Chinese medicine formulationsLI Qing-na, LU Fang, GAO Rui113-120
Study on risk-sharing agreements in South Korea and its implication for medical insurance admission in ChinaZHANG Tian-qi, ZENG Liu-chun, ZHANG Wen, WANG Lin-ning, LU Yun121-127
Competitive situation analysis of RNA interference drugs based on patentsYUAN Ya-kun, XIAO Yu-feng, ZHANG Bin128-140
The current status,challenges and strategies of China's innovative drug exports to Association of Southeast Asian Nations——A PEST analysisWANG Zhang-ke, PEI Xiao-yu, XING Bing-ke, SHENG Tian-yi, JIANG Rong, SHAO Rong141-148
Analysis and reflection on the on-site inspections of registration and manufacturing of innovative therapeutic biological productsLIN Juan, XU Dan, QIAO Li-tao, ZHOU Gang149-153
Preclinical evaluation of arrhythmogenic risk of traditional Chinese medicines:technical progress and reflections based on international drug safety assessment methodsWANG Xuan-yang, ZHU Ming-jun, LI Bin, YU Rui, WANG Jian-ru, SUN Yu-die, DING Hao, ZHANG Wen-ping, YAN Gan-xin, GAO Yuan154-161
Advances in mass spectrometry imaging and its application in studying heterogeneous drug distributionLIU Mao-mei, YE Xiao, HUANG Shu-jia, WANG Yu, WEN Nie, ZHANG Jia-ning, LIU Zhong-bo, LIU Ying162-171
Construction of a competency evaluation system for clinical research coordinators and its application in oncology drug clinical trialsJIANG Min, LIU Xiao-hong, ZHAO Shu-hua, SHEN Wan-li, HUANG Jun, MEI Yun, GAO Pan-jun172-176
Quality management practice of vaccine trial research institutionsFENG Tian, ZHANG Rui-zhi, GUAN Qing-hu, GAO Yuan-xue, JIAO Yu-hang, CHEN Hu, CHEN Zai-qin, HUANG Xiao-chan, MU Qiu-yue177-182
Investigation of the therapeutic mechanism of Heqi San in diabetes mellitus through network pharmacology and diabetic rat modelLIAN Li-rong, SHU Xiao, HUANG Bao-li, XIE Wei, HE Jin-lian, LI Run-ze, ZHAO Heng-xia, LIU Liang183-192